Determine in vitro susceptibility to antimicrobial agents for viridans streptococci.
New York DOH Approval Status
Actively growing isolate in pure culture.
Transport sealed container with pure culture on agar slant. Place each specimen in individually sealed bag.
Mixed cultures or non-viable organisms.
Isolate identification and specimen source required.
Ambient: 1 week; Refrigerated: Unacceptable; Frozen: Unacceptable
Susceptible, intermediate, or resistant.
Susceptibility testing is performed by CLSI-approved broth microdilution method using custom made MIC panels.
Depends on Specimen/Source/Method
The following agents will be tested: ceftriaxone, clindamycin, daptomycin, doxycycline, erythromycin, gentamicin, meropenem, levofloxacin, penicillin, rifampin, trimethoprim-sulfamethoxazole, and vancomycin. Selective reporting by organism and source.
An additional processing fee will be billed for all organisms not submitted in pure culture, as indicated in the specimen requirements.
If species identification is not provided, identification will be performed at ARUP. Additional charges apply.
|Component Test Code*||Component Chart Name||LOINC|
|0060222||Susceptibility, Viridans Streptococcus||29576-6|
- Beta-hemolytic streptococcus
- streptococcus anginosus
- V streptococci susceptibility
- Viridans Streptococci Susceptibility Panel